|[June 24, 2014]
Dassault Systèmes' 3DEXPERIENCE Platform Selected by Ion Beam Applications to Streamline Development of Cancer Therapy Solutions
VELIZY-VILLACOUBLAY, France --(Business Wire)--
Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company,
world leader in 3D design software, 3D Digital Mock Up and Product
Lifecycle Management (PLM) solutions, announced today that Ion Beam
Applications SA (IBA), the leading medical device manufacturer and
pioneer in proton beam therapy for cancer treatment, selected the
3DEXPERIENCE platform based on V6 architecture, and its "Licensed to
Cure for Medical Device" industry solution experience. With "Licensed to
Cure for Medical Device", IBA will support the development processes of
its medical accelerator solutions.
The changing medical needs of a growing world population, along with
advances in medical research, place extreme challenges on medical device
manufacturers to accelerate development of innovative and safe equipment
that comply with stringent national and international regulations. IBA
wanted to transition from a labor-intensive engineered-to-order approach
to a standardized collaborative development approach that results in an
extensive series of production-ready machines that fit a variety of
complex customers' demands.
Thanks to "Licensed to Cure for Medical Device," IBA's lobal teams get
a centralized access to the most up to date design, regulatory and
quality information, ensuring regulatory compliance. Users spend little
time looking for product data when they need to respond to a regulatory
body's request for information. IBA has full traceability and can
tightly secure its corporate intellectual property. This helps maintain
its competitive edge against other medical device companies.
"With 'Licensed to Cure for Medical Device' we will have a single
unifying development framework in which we can capitalize all our data,
processes and methodologies for future reuse, and from there improve the
productivity of all downstream processes." said Thomas Canon (News - Alert), PLM
Program Manager at IBA.
"Medical device manufacturers have a dual responsibility: to patients
for innovative therapeutic solutions, and to regulatory bodies that must
ensure that their equipment abides by stringent safety and quality
protocols," said Monica Menghini, Executive Vice President, Corporate
Strategy, Industry and Marketing, Dassault Systèmes (News - Alert). "The integrated
'Licensed to Cure for Medical Device' industry solution experience gives
the Life Science Industry a competitive means to provide a faster reply
to operators' needs and, ultimately, faster accessibility to therapies
for the patients."
For more information on Dassault Systèmes' industry solution experiences
for the life sciences industry, please visit www.3ds.com/industries/life-sciences/.
About Dassault Systèmes
Dassault Systèmes, the 3DEXPERIENCE Company, provides business and
people with virtual universes to imagine sustainable innovations. Its
world-leading solutions transform the way products are designed,
produced, and supported. Dassault Systèmes' collaborative solutions
foster social innovation, expanding possibilities for the virtual world
to improve the real world. The group brings value to over 190,000
customers of all sizes, in all industries, in more than 140 countries.
For more information, visit www.3ds.com.
CATIA, SOLIDWORKS, ENOVIA, DELMIA, SIMULIA, GEOVIA, EXALEAD, 3D VIA (News - Alert),
3DSWYM, BIOVIA, NETVIBES, and 3DXCITE are registered trademarks of
Dassault Systèmes or its subsidiaries in the US and/or other countries.
[ Back To TMCnet.com's Homepage ]